Cargando…
Development of an Indirect ELISA to Detect Equine Antibodies to Theileria haneyi
The apicomplexan parasite Theileria haneyi is one of two known causative agents of equine theileriosis. It causes milder clinical disease than its more virulent counterpart, Theileria equi, in experimentally infected horses, and can superinfect T. equi-positive horses. The current equi merozoite ant...
Autores principales: | Bastos, Reginaldo G., Sears, Kelly P., Dinkel, Kelcey D., Kappmeyer, Lowell, Ueti, Massaro W., Knowles, Donald P., Fry, Lindsay M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997436/ https://www.ncbi.nlm.nih.gov/pubmed/33673478 http://dx.doi.org/10.3390/pathogens10030270 |
Ejemplares similares
-
Imidocarb Dipropionate Lacks Efficacy against Theileria haneyi and Fails to Consistently Clear Theileria equi in Horses Co-Infected with T. haneyi
por: Sears, Kelly, et al.
Publicado: (2020) -
Clinical Progression of Theileria haneyi in Splenectomized Horses Reveals Decreased Virulence Compared to Theileria equi
por: Sears, Kelly P., et al.
Publicado: (2022) -
Changes in the Molecular and Functional Phenotype of Bovine Monocytes during Theileria parva Infection
por: Bastos, Reginaldo G., et al.
Publicado: (2019) -
Isolation of infectious Theileria parva sporozoites secreted by infected Rhipicephalus appendiculatus ticks into an in vitro tick feeding system
por: Vimonish, Rubikah, et al.
Publicado: (2021) -
Tulathromycin and Diclazuril Lack Efficacy against Theileria haneyi, but Tulathromycin Is Not Associated with Adverse Clinical Effects in Six Treated Adult Horses
por: Onzere, Cynthia K., et al.
Publicado: (2023)